Damien Tappy
Net worth: 3 M $ as of 31/05/2026
Net worth: 3 M $ as of 31/05/2026
Damien Tappy is the founder of École Polytechnique Fédérale de Lausanne.
Current jobs include Independent Non-Executive Director at Medartis Holding AG since 2018, Director at La Tour Holding SA, Director at Polares Medical SA since 2017, Director at CeQur SA since 2010, Director at Medartis AG since 2018, Director at Hopital De La Tour SA since 2018, Director at L’Enfance since 2007, Member of Young Presidents' Organization, Inc., President and Managing Partner at Endeavour Vision SA since 2012, and Member of Fondation Du Domaine De Villette.
Former jobs include Chairman at Bitplane AG, Chairman at utribo SA, Chairman at GeneSystems SA from 2006 to 2008, Director at Cirpack SASU, Director at Polytech Advisors SA, Director at Symetis SA from 2010 to 2017, and Managing Partner at Endeavour Advisors SA. Education includes undergraduate degree from École Polytechnique Fédérale de Lausanne and undergraduate degree from International Institute for Management Development.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDARTIS HOLDING AG 0.23% | 31/12/2025 | 30,705 ( 0.23% ) | 3 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| MEDARTIS HOLDING AG | Director/Board Member | 01/01/2018 |
Medartis AG | Director/Board Member | 01/01/2018 |
Young Presidents' Organization, Inc.
Young Presidents' Organization, Inc. Miscellaneous Commercial ServicesCommercial Services Provides professional membership services | Corporate Officer/Principal | - |
La Tour Holding SA
La Tour Holding SA Medical/Nursing ServicesHealth Services Provides medical specialties services | Director/Board Member | - |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany. Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions. EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired. | President | 11/04/2000 |
Polares Medical SA
Polares Medical SA Medical SpecialtiesHealth Technology Operates as a medical device company with a novel devices for treating mitral valve regurgitation | Director/Board Member | 01/01/2017 |
CeQur SA
CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients | Director/Board Member | 25/11/2010 |
Hopital De La Tour SA | Director/Board Member | 01/01/2018 |
| Companies | Position | End |
|---|---|---|
Polytech Advisors SA
Polytech Advisors SA Investment ManagersFinance Acts as an alternative investment manager | Director/Board Member | 10/01/2012 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 17 |
|---|---|
École Polytechnique Fédérale de Lausanne
École Polytechnique Fédérale de Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endeavour Advisors SA
Endeavour Advisors SA Investment ManagersFinance Acts as an alternative investment manager | Finance |
GeneSystems SA
GeneSystems SA Pharmaceuticals: MajorHealth Technology Develops and commercializes innovative biotechnology diagnostics products | Health Technology |
Cirpack SASU
Cirpack SASU Electrical ProductsProducer Manufacturing Manufactures and supplies softswitch platforms | Producer Manufacturing |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symetis SA
Symetis SA BiotechnologyHealth Technology Develops products for pediatric cardio-vascular applications | Health Technology |
Young Presidents' Organization, Inc.
Young Presidents' Organization, Inc. Miscellaneous Commercial ServicesCommercial Services Provides professional membership services | Commercial Services |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance EV develops a long-term investment strategy with their entrepreneurs. Their investment objective is to grow firms and to create a market leader in a new field. They focus on developing businesses active in industries including information technology, biotech, medtech and cleantech. They concentrate on various stages such as early to expansion-stage as well as spin-offs and restarts. Their geographic focus is pan-European. Specifically, their technology-sector investments are concentrated in Norway, Sweden, Finland, UK, Ireland, Germany, Switzerland, France, Italy and Portugal. Beyond these countries, they also consider taking a co-lead or a syndicate role. For their life sciences investments, they primarily target Switzerland, France and Germany. Four key investment criteria they consider before investment are hyper-growth market potential, world-class technology, capital efficiency and ambitious management team. EV's preferred role is to be lead investor or possibly co-lead. They also consider being syndicate partner on some occasions. EV's investment horizon is generally 10 years, with that timeframe extended for firms in hyper-growth stage. On average, their investments typically take five years to mature. The majority of their exits are through a listing in one of the main markets while many of the VC-backed firms are acquired. | Finance |
Polytech Advisors SA
Polytech Advisors SA Investment ManagersFinance Acts as an alternative investment manager | Finance |
Bitplane AG
Bitplane AG Information Technology ServicesTechnology Services Develops interactive visualization and analysis software | Technology Services |
CeQur SA
CeQur SA Medical SpecialtiesHealth Technology Develops medical devices for diabetes patients | Health Technology |
utribo SA
utribo SA Information Technology ServicesTechnology Services Provides telecommunications solutions | Technology Services |
Medartis Holding AG
Medartis Holding AG Medical SpecialtiesHealth Technology Designs and manufactures orthopedic devices | Health Technology |
La Tour Holding SA
La Tour Holding SA Medical/Nursing ServicesHealth Services Provides medical specialties services | Health Services |
Polares Medical SA
Polares Medical SA Medical SpecialtiesHealth Technology Operates as a medical device company with a novel devices for treating mitral valve regurgitation | Health Technology |
Medartis AG | |
Hopital De La Tour SA |
Select your edition
All financial news and data tailored to specific country editions